Management of Post-Thoracentesis Cough

Rationale for Use

Cough is a recognized limiting symptom during thoracentesis, particularly when removing large volumes of fluid (>1.5 L), and serves as a clinical indicator to stop fluid removal, as noted by the American Thoracic Society 1, 2, 3
The cough results from rapid pleural pressure changes and mechanical forces during lung re-expansion, according to the American Journal of Respiratory and Critical Care Medicine 3

The American College of Chest Physicians recommends levodropropizine for short-term symptomatic relief of coughing in patients with chronic or acute bronchitis (Grade A recommendation) 4
Post-thoracentesis cough that persists beyond the immediate procedure may be treated with levodropropizine, as suggested by the American Journal of Respiratory and Critical Care Medicine 3
Confirmed absence of recurrent pleural effusion (by imaging or clinical assessment) is necessary before using levodropropizine, as recommended by the Thorax journal 2
Symptomatic relief with levodropropizine is appropriate while monitoring for potential recurrence, according to the Thorax journal 1, 2

The American College of Chest Physicians advises against using antitussives to mask symptoms of recurrent effusion, and instead recommends ruling out recurrent effusion first 5
Recurrence rate after thoracentesis alone approaches 100% at 1 month in malignant effusions, highlighting the need for careful monitoring, as noted by the Thorax journal 1, 2
New or worsening cough warrants repeat imaging to exclude re-accumulation before treating symptomatically, as recommended by the Thorax journal 1
Persistent cough may indicate complications such as trapped lung, re-expansion pulmonary edema, pneumothorax, or empyema, according to the American Journal of Respiratory and Critical Care Medicine and the Thorax journal 1, 2, 3